The results showed that silencing the expression of PTOV1-AS2 reduced the tumorigenic capacity of colon cancer cells, as evidenced by lower tumor weight (Figure 5(b)) and volume (Figure 5(c)). This evidence concerns the gene PTOV1 and colonic neoplasm.